Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Renal Cell

Explore clinical trials studying Carcinoma, Renal Cell. Study availability and eligibility vary by location and protocol.

1,363 public trials 252 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Renal Cell trial results

Recruiting

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

NCT07115043

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +58 more
Locations
  • Research Site Grand Rapids, Michigan, United States
  • Research Site St Louis, Missouri, United States
  • Research Site Pittsburgh, Pennsylvania, United States
  • Research Site Houston, Texas, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of Enzelkitug as a Single Agent and in Combination With Checkpoint Inhibitor in Participants With Locally Advanced or Metastatic Solid Tumors

NCT05581004

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +57 more
Locations
  • Stanford University San Francisco, California, United States
  • University Of Colorado Aurora, Colorado, United States
  • Florida Cancer Specialists - Sarasota Sarasota, Florida, United States
  • Winship Cancer Institute Atlanta, Georgia, United States
View all 41 locations
View Trial Details
Recruiting

Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer

NCT07227415

Conditions
Adenocarcinoma, Advanced Renal Cell Carcinoma, Advanced or Metastatic Renal Cell Carcinoma, +30 more
Locations
  • Mayo Clinic Building- Phoenix Phoenix, Arizona, United States
  • Mayo Clinic Arizona Scottsdale, Arizona, United States
  • Highlands Oncology Group Fayetteville, Arkansas, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
View all 128 locations
View Trial Details
Recruiting

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

NCT06661720

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +17 more
Locations
  • Cancer Center at Saint Joseph's Phoenix, Arizona, United States
  • Banner University Medical Center - Tucson Tucson, Arizona, United States
  • University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
View all 415 locations
View Trial Details
Recruiting

A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors

NCT05536141

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +16 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site San Diego, California, United States
  • Research Site Santa Monica, California, United States
  • Research Site Miami, Florida, United States
View all 25 locations
View Trial Details
Recruiting

A Study of BMS-986488 as Monotherapy and Combination Therapy in Participants With Advanced Malignant Tumors

NCT06764771

Conditions
Adenocarcinoma, Advanced Malignant Tumors, Bronchial Neoplasms, +31 more
Locations
  • John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States
  • Local Institution - 0020 Allentown, Pennsylvania, United States
  • The West Clinic, PLLC dba West Cancer Center Germantown, Tennessee, United States
  • Local Institution - 0025 Dallas, Texas, United States
View Trial Details

Related conditions